How Does It Work
Rezm uses radiofrequency to heat water into vapor , which is then injected directly into prostate. Vapor turns into water on contact with the prostate tissue, creating controlled damage to the cells that cause obstruction, discomfort, and symptoms associated with BPH. Over time , your body will absorb and remove the treated tissue through the natural healing response.
Center For Cancer Genetics
For decades, geneticists working in Utah have made seminal contributions to the field of cancer predisposition genetics. The Center for Cancer Genetics at Huntsman Cancer Institute continues our leadership through comprehensive translation of cancer susceptibility gene discoveries to the clinic and to the population.
Metastatic Prostate Cancer Os Up Markedly
Access to therapies approved over the last decade has significantly lengthened median survival times in patients with metastatic hormone-sensitive prostate cancer. That conclusion comes from a large randomized clinical trial that tested a new treatment for these patients.
The S1216 study was conducted by researchers from SWOG Cancer Research Network, a cancer clinical trials group funded by the National Cancer Institute . It tested the efficacy of the drug orteronel in these patients, pairing it with androgen deprivation therapy on the investigational arm and comparing that combination to androgen deprivation therapy plus bicalutamide. The results are published in the Journal of Clinical Oncology.
Although the study missed the primary endpoint of a 33 percent improvement in overall survival , it also showed an unprecedented median OS of 70 months in the control arm, the highest ever reported for these patients on a non-intensified androgen deprivation therapy arm. This OS is a 24 month improvement over results reported in 2013 from the SWOG-9346 trial, which enrolled a nearly identical proportion of patients with extensive disease.
Men on the orteronel arm also had significantly improved median progression-free survival and prostate-specific antigen response rates measured at seven months after the start of treatment these were secondary endpoints in the trial.
Read Also: How To Take Care Of Prostate Health
Cancer Center Research Programs
Huntsman Cancer Institute at the University of Utah is a National Cancer Institute-Designated Comprehensive Cancer Center. The Cancer Center Support Grant provides funding for four research programs, each focused on a specialized aspect of basic, translational, and clinical cancer research performed by more than 135 members of our Cancer Center. These programs promote scientific excellence through coordinated, broad-based transdisciplinary research.
Improving Quality Of Life
Improving quality of life for patients with GU cancers is important to our researchers. Prostate cancer treatments can change a mans quality of life. Our team has come up with a new way to give patients information about the possible changes. The information is framed as best, worst, and most likely outcomes. Patients can make more effective treatment decisions when the outcomes are framed this way.
HCI participates in a large national trial for men with early-stage prostate cancer. The trial compares how effective surgery, radiation, and watchful waiting treatments are. It also looks at quality of life differences between the treatment types.
Recommended Reading: New Radiation Treatment For Prostate Cancer
Cancer Care In Wyoming & Utah
The Huntsman Cancer Institute is a cancer research and treatment facility at the University of Utah Health. Through scientific study and comprehensive research endeavors, they have made great strides in cancer treatments. Their work has partnered them with some of the worlds leading cancer centers, and St. Johns Health is proud to be one of their affiliates.
As partners, our two facilities collaborate so that residents of Jackson Hole and the surrounding areas have access to a wide array of cancer specialists from one of the countrys top cancer institutes.
Who Can Visit The Clinic
The Prostate Cancer Risk Clinic is for men ages 35-70 who meet one or both of the following criteria:
Also Check: How Does A Doctor Check Your Prostate
Hereditary Prostate Cancer Linked To Family History Of Breast Ovarian Cancer
Most men and their doctors know to be extra vigilant if there’s a family history of prostate cancer, which adds heightened risk for the disease.
But what often gets overlooked is the man’s female relatives. If mothers, sisters and daughters have a history of breast and ovarian cancers, possibly stemming from mutations in genes like BRCA1/2, a man’s risk for prostate cancer is also significantly increased, and this information should be included in family histories to guide screening, testing and treatment.
That finding, in a study led by Kathleen Cooney, MD, professor and chair of the Duke University Department of Medicine, published March 24 in the Journal of Clinical Oncology.
Previous studies have shown that certain cancers — including breast, ovarian, pancreatic and prostate — are linked by the inheritable mutations BRCA1 and BRCA2 genes. Cooney and her team built on that existing knowledge by using the Utah Population Database to examine the health and family history records of approximately 620,000 men over the age of 40. They also examined the risk of prostate cancer in men with a family history consistent with Lynch Syndrome, also known as hereditary nonpolyposis colorectal cancer.
Other co-authors on the paper include Jennifer L. Beebe-Dimmer, Ashley Kapron, Alison M. Fraser and Ken R. Smith.
There Are208doctors Who Treat Prostate Cancer In Salt Lake City Find The Best For You:
- Rated 4.70 out of 5 stars, with 1250 East 3900 South Ste 100Salt Lake City, UT84124
- Rated 4.90 out of 5 stars, with 620 East Medical Dr Ste 150Bountiful, UT84010
- Rated 4.30 out of 5 stars, with 1950 Circle of Hope DrSalt Lake City, UT84112
- Rated 4.60 out of 5 stars, with 24 S 1100 E Ste 306Salt Lake City, UT84102
- Rated 3.40 out of 5 stars, with 4252 South Highland Dr Ste 200Salt Lake City, UT84124
- Rated 3.80 out of 5 stars, with 1050 E South TempleSalt Lake City, UT84102
- Rated 3.60 out of 5 stars, with 1060 East 100 South Ste 110Salt Lake City, UT84102
- Rated 4.50 out of 5 stars, with 1280 E Stringham AveSalt Lake City, UT84106
- Rated 3.40 out of 5 stars, with 4252 S Highland Dr Ste 200Salt Lake City, UT84124
- Rated 5.00 out of 5 stars, with 127 S 500 E Ste 600Salt Lake City, UT84102
- Rated 3.20 out of 5 stars, with 5171 S Cottonwood St Ste 720Salt Lake City, UT84107
Also Check: What Is Focal Therapy For Prostate Cancer
Learning New Ways To Find And Treat Gu Cancers
Cancers release substances called molecular markers into blood, other body fluids, or tissues. These markers can confirm the presence and type of cancer without surgical biopsies. Researchers in the GU Cancers Center are identifying these markers for all GU cancers, in particular prostate and bladder cancers.
For example, in about half of men who have prostate cancer, their tumor cells have DNA changes that rearrange two genes. These rearranged genes can signal how fast the cancer may grow and spread. Center members have already found a fast, simple test to measure how these two genes work in tumors. Now they are comparing test results from prostate cancer tumors to treatment outcomes of past patients. The results will show whether doctors can use this test to predict which prostate cancers are likely to be life-threatening. Then they can personalize treatment plans to meet each patients needs based on these cancer DNA tests.
To Gauge Prostate Cancer Risk Explore More Family Ties
When it comes to prostate cancer, its not enough for a clinician to ask whether a mans parents or other first-degree relatives had the disease. Broadening the family history and inquiring about uncles, grandparents and great-grandparents can help identify patients at high risk for the disease and can help determine who should have a blood test for screening.
The so-called PSA or prostate-specific antigen blood test for the disease is controversial because of the high rate of false positives. Prostate enlargement, which frequently occurs with age or an infection, can lead doctors to suspect cancer when it is not there, resulting in painful and unnecessary biopsies.
To find out who might benefit most from testing, researchers at the University of Utahs Huntsman Cancer Institute obtained information on family prostate cancer history from 7.3 million people in the Utah Population Database. Then they developed individualized risk estimates for men based on their first-, second- and third-degree relatives experiences.
Based on the number of relatives who had the disease, researchers determined that 10 percent of the men had three times the risk of developing the disease and 26 percent had double the risk compared to those with no family history of prostate cancer.
Results of the study funded by the U.S. Department of Defense, the National Institutes of Health and the Huntsman Cancer Foundation were published in The Prostate journal.
Also Check: High-risk Prostate Cancer Life Expectancy
When I Visit The Clinic What Will I Do
- Review your personal and family health history and lifestyle factors that may contribute to prostate cancer risk
- Have blood and urine testing to screen for prostate cancer
- Get a physical exam
- Talk with a clinic team member about your individual screening plan and follow-up care based on test results
- Get a prostate biopsy if test results are abnormal
- Talk with a doctor or genetic counselor about the chance to take part in a research study about prostate cancer risk
Diagnosis Of Prostate Cancer
Doctors use these tests to diagnose prostate cancer:
- Physical exam and history: A health care provider examines your body for signs of disease. Your personal health habits, past illnesses, and symptoms help guide the exam.
- Digital Rectal Exam : A health care provider inserts a lubricated, gloved finger into the rectum and feels the prostate through the rectal wall, checking for lumps or abnormal areas.
- Prostate-specific antigen test: This test measures the level of PSA, a substance made by the prostate, in the blood.
- Transrectal MRI : This test uses a magnet, radio waves, and a computer to make detailed images of the prostate.
- Biopsy: The health care provider removes cell or tissue samples so they can be viewed under a microscope to check for signs of cancer.
- Transrectal ultrasound: This procedure uses high-energy sound waves to create a picture of prostate tissue. The health care provider gently inserts a lubricated probe into the rectum.
You May Like: Prostate Cancer Marker Blood Test
Choose Rezm To Treat Your Bph
Rezm offers multiple benefits over traditional therapies:
- Potential alternative to BPH medications
- Relieves symptoms safely and effectively1
- Provides noticeable symptom improvement within two weeks1
- Simple in-office, out-patient therapy
- Does not require general anesthesia
- Preserves sexual and urinary functions1
- Allows patients to return to regular activities within a few days1
Snmmi Dinner Symposium: Expanding Survival In Prostate Cancer With New Theranostics Treatment
Free SNMMI Dinner Symposium:Expanding Survival in Prostate Cancer with New Theranostics Treatment
Date: July 28, 2022Time: 5:30 – 8:30 pm MDTLocation: Grand America Hotel, 555 S. Main St., Salt Lake City, UT 84111Fee: Complimentary
SNMMI has applied for 2 hours of CE Credit for this in-person event.Please note that seating is limited and registration will be available on a first-come, first-served basis.
Registration for this event is now closed.
SCHEDULE
6:15-8:30 pm Educational ProgramSeveral new radiopharmaceuticals are now being used to stage and identify local and metastatic prostate cancer, including the recently approved Ga-68 PSMA-11 and 18F-DCFPyL. In addition, the FDA in March approved Lu 177 vipivotide tetraxetan to treat PSMA-positive metastatic castration-resistant prostate cancer. Given these new advancements in diagnosis and treatment, how does one navigate the changing landscape to provide the best outcomes for the patient?
6:15 pmOpening RemarksSatoshi Minoshima, MD, PhD, Anne G. Osborn Chair and Professor, Department of Radiology and Imaging Sciences, Spencer Fox Eccles School of Medicine, University of Utah and Don Milligan, MBA, Cancer Hospital Executive Director, Huntsman Cancer Institute, University of Utah Health
6:20 pmMetastatic Castration-Resistant Prostate Cancer and the VISION TrialBenjamin L. Maughan MD, PharmD, Assistant Professor, Genitourinary Medical Oncology, Huntsman Cancer Institute, University of Utah
7:05 pm
You May Like: Can Prostate Cancer Be Cured With Radiation
What This Means For Teton County Patients With Cancer
Having led some of the nations most influential cancer studies, the HCI oncologists have a great deal of knowledge and experience to offer cancer care professionals. Our staff is privileged to participate in educational courses at the Institute and train in some of the most effective cancer treatments normally only found at large cancer centers. This means our patients have access to large hospital resources in our small, rural Wyoming town.
The HCI and St. Johns affiliation provides us with access to:
- New developments in cancer research
- Specialized cancer treatments
How Do I Find Out More
Theres lots of information available on our website, including more information about:
You can also speak to our Specialist Nurses on 0800 074 8383, or by email, Live Chat, social media or SMS. They can talk to you, a partner or anyone else at risk of prostate cancer about the risk factors and the tests used to help diagnose prostate cancer.
You May Like: How Do You Know If Prostate Cancer Has Spread
High Risk Cancer Research Clinics & Studies
The High Risk Cancer Research Clinics provide information for investigations into the genetics and inheritance of cancer. They provide education, and in some cases cancer screening services, for individuals and families with an increased risk of developing cancer. Through these clinics, eligible participants may enroll in cancer research studies. Physicians, genetic counselors, research coordinators, and other support personnel provide a multidisciplinary approach to patient care.
The Importance Of Your Contributions To The Huntsman Cancer Foundation In Support Of Prostate Cancer Research
Did you know that women have about a 1 in 8 chance of developing breast cancer, and men have about a 1 in 9 chance of developing prostate cancer in their lifetime? Either of these diagnoses will upend the lives of many men, women, and their families. Yet, what most people dont know is that the taxpayer funded National Institutes of Health spends three times more money on breast cancer research than prostate cancer research, and that private research contributions to breast cancer research can be 4 or more times as high than prostate cancer research. The reasons for this imbalance are several and complex, but much of it revolves around the idea that men are simply not as proactive about their health as a group. It is time for this apathy about Mens health to change.
The team of doctors and researchers at the Huntsman Cancer Institute need your help to make eradicating prostate cancer a priority. As a National Cancer Institute designated Comprehensive Cancer Center, we have all the tools in place to make a real difference RIGHT NOW. We have organized our research efforts into the following pillars:
We need your help. Did you know that every single dollar that is contributed to the Huntsman Cancer Foundation for prostate cancer research is provided to the researchers directly, without any removed for organizational overhead?
Don’t Miss: Robotic Prostate Surgery Side Effects
Huntsman Cancer Institute Begins Treatment With Mevion Compact Proton Therapy System
The teams from HCI, U of U and Mevion gather to celebrate the centers grand opening. Group from left to right: Bill Salter, Ph.D., Senior Director of Radiation Oncology, HCI and Professor and Chief of the Division of Medical Physics, U of U — Robyn Walker, Sr. Director, Customer Success and Service Operations, Mevion — James Cooley, Ph.D., Director of Advanced Development, Mevion — Dennis Shrieve, M.D., Ph.D., Chair in Cancer Research, HCI and Chair of Department of Radiation Oncology, U of U — Tina Yu, Ph.D., CEO, Mevion — Michael Good, M.D., Interim President, U of U and Sr. VP for Health Sciences, U of U Health — Ying Hitchcock, M.D., Professor and Medical Director, Department of Radiation Oncology, U of U.
June 24, 2021 Mevion Medical Systems announced that the first proton center in the Mountain West, the Senator Orrin G. Hatch Center for Proton Therapy, has opened at Huntsman Cancer Institute at the University of Utah and began treating patients on May 11 with the MEVION S250i Proton Therapy System. Despite the challenges of the COVID-19 pandemic, the Mevion team successfully installed the MEVION S250i in 7 months from the delivery of the accelerator.
HCI is the only National Cancer Institute-designated Comprehensive Cancer Center in the Mountain West and serves a geographic region that includes all of Utah, Idaho, Montana, Nevada, and Wyoming.
For more information: www.mevion.com
Information To Help You Talk To Your Gp
Before you speak to your GP, you might find it helpful to fill out this information sheet. It has space to write down any risk factors or symptoms you have and lists questions you might want to ask your doctor.
You could have the sheet in front of you when you talk to your GP, to help guide your conversation.
Read Also: Aggressive Prostate Cancer Survivor Stories
Utah Billionaire Jon Huntsman Opens New Children’s Cancer Research Center
Chemicals billionaire Jon Huntsman Sr. is one of the worlds great optimists. His mom died of cancer in her 50s, and hes battled four different forms of the disease. His response was to launch the Huntsman Cancer Institute at the University of Utah in the 1990s. His audacious goal: to eradicate the most challenging forms of cancer in one generation. Then, says his son, Peter Huntsman, only half joking, with cancer research beat, he hopes theyll be able to turn the cancer institute into a hotel.
Weve made such enormous progress with research, Jon Huntsman Sr. said in an interview in his photo-festooned office at the Huntsman Cancer Foundation in Salt Lake City. When I had prostate cancer 25 years ago, I spent 11 days in the hospital. Today with prostate cancer, we can do it robotically, and youre out in 36 hours.
Jon Huntsman Sr. at the June 21, 2017 unveiling ceremony for a new wing of the Huntsman Cancer… Institute, with 11-year-old Andrew Van Wagoner, who collected $119 for the center.
Charlie Ehlert, University of Utah Health
Huntsman Sr.s resolute optimism extends to his own health. Hes had to undergo 24 surgeries in the past decade to replace bones and cartilage that have disintegrated due to a disease he has called polymyalgia rheumatica. I think my 80s are going to be a lot more pleasant that my 70s, he said, grinning.